Long-term stabilisation of myeloma with curcumin.

Related Articles

Long-term stabilisation of myeloma with curcumin.

BMJ Case Rep. 2017 Apr 16;2017:

Authors: Zaidi A, Lai M, Cavenagh J

Abstract
Myeloma is a haematological malignancy which typically follows a relapsing-remitting course. While treatment can control the myeloma and improve quality of life for given periods of time, remissions generally become progressively shorter with subsequent relapses, and patients ultimately enter a final refractory phase. To help control symptoms and enhance quality of life, some patients use complementary therapies as an adjunct to their conventional therapy. Here, we describe a myeloma patient who started a daily dietary supplement of curcumin when approaching her third relapse. In the absence of further antimyeloma treatment, the patient plateaued and has remained stable for the last 5 years with good quality of life.

PMID: 28413157 [PubMed - indexed for MEDLINE]

http://ift.tt/2to1ScJ